Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry [Structural Heart Disease]
Conclusions—
Our data establish the magnitude of short- and long-term risk conferred by DM and the incremental risk conferred by insulin dependency in the performance of TAVR.
Clinical Trial Registration—
URL: https://www.clinicaltrials.gov. Unique identifier: NCT01737528.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Abramowitz, Y., Vemulapalli, S., Chakravarty, T., Li, Z., Kapadia, S., Holmes, D., Matsouaka, R. A., Wang, A., Cheng, W., Forrester, J. S., Smalling, R., Thourani, V., Mack, M., Leon, M., Makkar, R. R. Tags: Aortic Valve Replacement/Transcatheter Aortic Valve Implantation Structural Heart Disease Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Clinical Trials | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Disease | Heart Valve Surgery | Insulin